Policy | August 27, 2024
India's bioeconomy to reach US $300 billion by 2030: Dr. Jitendra Singh
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Approval based on MIRACLE Phase III trial demonstrating a significant and clinically meaningful reduction in asthma exacerbations and improvement in asthma symptom control
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
The brand will establish an integrated hearing care ecosystem at Neuberg Diagnostics centers across the length and breadth of the country
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
AGEasy has made significant strides in addressing the pressing health concerns of seniors in India
Subscribe To Our Newsletter & Stay Updated
